JACC. Clinical electrophysiology · 2025
Premature Ventricular Complexes and Nonsustained Ventricular Tachycardia in Cardiac Sarcoidosis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
de Melo Jose F, Debertin Julia, Castrichini Matteo, Rosenbaum Andrew N, Bois John P, Giudicessi John R, Kafil Tahir S, Deshmukh Abhishek J, Kapa Suraj, Sugrue Alan M, Killu Ammar M, Del-Carpio Munoz Freddy, DeSimone Christopher V, Kowlgi Gurukripa, Tan Nicholas Y, Ezzeddine Fatima M, Asirvatham Samuel J, Abou Ezzeddine Omar F, Siontis Konstantinos C
Аннотация
BACKGROUND: The prevalence and prognostic significance of frequent premature ventricular complexes (PVCs) and nonsustained ventricular tachycardia (NSVT) in cardiac sarcoidosis (CS), especially in patients with normal or mildly decreased left ventricular function, have not been studied.
OBJECTIVES: This study sought to investigate the prognostic value of PVCs and NSVT in patients with CS and normal or mildly decreased left ventricular ejection fraction.
METHODS: The authors included 192 patients with definite or probable CS with left ventricular ejection fraction >35% and no previous history of ventricular tachycardia (VT)/ventricular fibrillation (VF) or sudden cardiac death, who underwent up to 48 hours of clinically indicated Holter monitoring. Baseline PVC burden and presence of NSVT were correlated with presence of fluorodeoxyglucose (FDG) uptake on positron emission tomography and late gadolinium enhancement (LGE) on magnetic resonance imaging. They performed multivariable analysis for the associations of PVC burden and NSVT with the composite endpoint of sustained VT/VF, advanced heart failure therapy, and all-cause mortality.
RESULTS: The median PVC burden was 0.3% (Q1-Q3: 0.02%-2.5%), and 36 (18.8%) patients had PVC burden ≥5%. Sixty-two patients (32.3%) had NSVT detected during Holter monitoring. PVC burden and NSVT had an association with LGE presence but not with FDG uptake. A total of 33 patients (17.2%) experienced the composite endpoint during a median follow-up of a 3 years. In multivariable analysis, PVC burden ≥5% vs <5% (HR: 2.84; 95% CI: 1.26-6.40; P < 0.01) and presence of NSVT (HR: 4.74; 95% CI: 2.15-10.46; P < 0.01) were associated with the composite endpoint.
CONCLUSIONS: These results suggest that an elevated PVC burden and the presence of NSVT are prognostically relevant and may have a role in the risk stratification of patients with CS.
OBJECTIVES: This study sought to investigate the prognostic value of PVCs and NSVT in patients with CS and normal or mildly decreased left ventricular ejection fraction.
METHODS: The authors included 192 patients with definite or probable CS with left ventricular ejection fraction >35% and no previous history of ventricular tachycardia (VT)/ventricular fibrillation (VF) or sudden cardiac death, who underwent up to 48 hours of clinically indicated Holter monitoring. Baseline PVC burden and presence of NSVT were correlated with presence of fluorodeoxyglucose (FDG) uptake on positron emission tomography and late gadolinium enhancement (LGE) on magnetic resonance imaging. They performed multivariable analysis for the associations of PVC burden and NSVT with the composite endpoint of sustained VT/VF, advanced heart failure therapy, and all-cause mortality.
RESULTS: The median PVC burden was 0.3% (Q1-Q3: 0.02%-2.5%), and 36 (18.8%) patients had PVC burden ≥5%. Sixty-two patients (32.3%) had NSVT detected during Holter monitoring. PVC burden and NSVT had an association with LGE presence but not with FDG uptake. A total of 33 patients (17.2%) experienced the composite endpoint during a median follow-up of a 3 years. In multivariable analysis, PVC burden ≥5% vs <5% (HR: 2.84; 95% CI: 1.26-6.40; P < 0.01) and presence of NSVT (HR: 4.74; 95% CI: 2.15-10.46; P < 0.01) were associated with the composite endpoint.
CONCLUSIONS: These results suggest that an elevated PVC burden and the presence of NSVT are prognostically relevant and may have a role in the risk stratification of patients with CS.